▲ S&P 500 +---%|▲ Stock Advisor +---%Join The Motley Fool

AccessibilityHelp

Leo Sun

TMFSunLion

Leo Sun is a contributing Motley Fool stock market analyst who has worked with the company since 2013, covering technology, consumer goods, industrial, and financial sectors. He became a self-made millionaire by age 40 through long-term investing, crediting lessons from Warren Buffett and Peter Lynch. Leo is a regular guest on CNBC Asia providing stock analysis on Chinese technology companies, including Tencent, Baidu, and Alibaba. He previously wrote for InvestorGuide and holds a bachelor’s degree in English from the University of Texas at Austin.

Articles by Leo Sun — Page 463

ffxiii2 2

Feb 11, 2014 by Leo Sun

‘Lightning Returns: Final Fantasy XIII’ Shows How Square Enix Is Destroying the Franchise

‘Lightning Returns: Final Fantasy XIII’ is a polarizing title that shows how much Square Enix’s flagship Final Fantasy franchise has changed over the past 27 years. Will this over-expansion of the franchise cause the series to implode?

Today’s Top Biotech Stories: Mallinckrodt, Regeneron, Arena, and Omeros

Feb 11, 2014 by Leo Sun

Today’s Top Biotech Stories: Mallinckrodt, Regeneron, Arena, and Omeros

Mallinckrodt, Regeneron, Arena, and Omeros could all loom large in health care headlines this morning. Here’s why.

ku-xlarge

Feb 11, 2014 by Leo Sun

AMC’s The Walking Dead Finally Got These 3 Things Right

The latest episode of AMC’s The Walking Dead, “After,” finally got these three things right. Did these vast improvements help it devour the Winter Olympics on NBC?

Today's Biggest Biotech Stories: Roche, Merck, Bayer, and Regeneron

Feb 10, 2014 by Leo Sun

Today's Biggest Biotech Stories: Roche, Merck, Bayer, and Regeneron

Roche, Merck, Bayer, and Regeneron could make health care headlines this morning. Here’s why.

3 Key Takeaways From Sanofi's Fourth-Quarter Earnings

Feb 9, 2014 by Leo Sun

3 Key Takeaways From Sanofi's Fourth-Quarter Earnings

Let’s discuss 3 key takeaways from Sanofi’s fourth-quarter earnings, and how competitors like Shire and Eli Lilly, and partners like Regeneron, could affect its growth in 2014.

Microsoft’s $100 Offer Exposes its Fear That Sony Will Win the PS4 vs Xbox One War

Feb 8, 2014 by Leo Sun

Microsoft’s $100 Offer Exposes its Fear That Sony Will Win the PS4 vs Xbox One War

Microsoft just offered $100 credit toward the purchase of an Xbox One to U.S. gamers who “ditch” their PS3s. Does this desperate move indicate just how afraid Microsoft is that Sony’s PS4 will emerge triumphant?

3 Key Takeaways From Teva's Fourth Quarter

Feb 7, 2014 by Leo Sun

3 Key Takeaways From Teva's Fourth Quarter

Let’s discuss 3 key takeaways from Teva’s fourth quarter earnings, and if rising competition in MS treatments from Novartis, Biogen, and Sanofi will eventually doom the company.

Marvel’s Agents of SHIELD Finally Got These 3 Things Right

Feb 6, 2014 by Leo Sun

Marvel’s Agents of SHIELD Finally Got These 3 Things Right

The latest episode of Marvel’s Agents of SHIELD, T.R.A.C.K.S., finally got the show back on the right track. Let’s take a look at 3 things the show finally got right.

These 4 Companies Could Alter the Future of Telehealth

Feb 6, 2014 by Leo Sun

These 4 Companies Could Alter the Future of Telehealth

New technologies from Google, Microsoft, iRobot, and Medtronic could dramatically alter the future of telehealth, or remote health care.

Watch Dogs, The Witcher 3, and Tom Clancy's The Division: A Closer Look at the 3 Most Anticipated Games of 2014

Feb 6, 2014 by Leo Sun

Watch Dogs, The Witcher 3, and Tom Clancy's The Division: A Closer Look at the 3 Most Anticipated Games of 2014

According to GameSpot Trax’s January survey, three games -- Watch Dogs, The Witcher 3, and Tom Clancy’s The Division -- are the most anticipated games of the year. Let’s take a closer look at these three titles.

transformers-age-of-extintion-prime-grimlock-820x358

Feb 5, 2014 by Leo Sun

‘Transformers: Age of Extinction’ Trailer Kicks Off a New Trilogy With Dinobots

The debut trailer for "Transformers: Age of Extinction," which aired during the Super Bowl, offered audiences their first peek at Michael Bay’s final film of the franchise. Will it be a step forward or a step back for the polarizing seven-year-old franchise?

Coca-Cola's 'America the Beautiful' Ad Reveals America's Ugliness

Feb 5, 2014 by Leo Sun

Coca-Cola's 'America the Beautiful' Ad Reveals America's Ugliness

Coca-Cola’s ad featuring a multilingual version of ‘America the Beautiful’ has sparked a hateful reaction from conservative critics.

Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014

Feb 5, 2014 by Leo Sun

Valeant's Inorganic Growth Could Threaten These 3 Companies in 2014

Valeant just made its first acquisition of the year. Let’s take a closer look at three companies -- Allergan, Actavis, and Zeltiq -- which could be threatened by the company’s inorganic growth.

What to Watch at Amgen, Merck, Pfizer, and Myriad Genetics This Morning

Feb 5, 2014 by Leo Sun

What to Watch at Amgen, Merck, Pfizer, and Myriad Genetics This Morning

Amgen, Merck, Pfizer, and Myriad Genetics could loom large in health care headlines today. Here’s why.

Could These Potential Catalysts Drive Lilly Higher?

Feb 4, 2014 by Leo Sun

Could These Potential Catalysts Drive Lilly Higher?

Could these two catalysts breathe some life back into Eli Lilly, which has remained flat over the past 12 months?

What to Watch at DexCom, Smith & Nephew, and Endo Health Solutions This Morning

Feb 4, 2014 by Leo Sun

What to Watch at DexCom, Smith & Nephew, and Endo Health Solutions This Morning

DexCom, Smith & Nephew, and Endo Health Solutions could be big health care stories this morning. Read on to find out why.

Yvonne-in-Chuck--yvonne-strahovski-722845_960_540

Feb 4, 2014 by Leo Sun

Will '24: Live Another Day' Resurrect the Canceled Series?

The Super Bowl ads for "24: Live Another Day" have whetted the appetites of 24 fans across America. But will this new limited series breathe new life into the franchise, or remind us why the show was canceled in the first place?

maxresdefault

Feb 3, 2014 by Leo Sun

Dragon Age: Inquisition, Mass Effect 4, and the Business of Video Game Romances

Bioware promises that Dragon Age: Inquisition and Mass Effect will feature new takes on the video game romance. Should gamers expect drastic gameplay changes in these eagerly anticipated titles?

What to Watch at Merck, CytRx, and Mylan This Morning

Feb 3, 2014 by Leo Sun

What to Watch at Merck, CytRx, and Mylan This Morning

Merck, CytRx, and Mylan are 3 health care stocks worth watching this morning. Here’s why.

Google Could Disrupt These 3 Medical Industries Within 10 Years

Feb 1, 2014 by Leo Sun

Google Could Disrupt These 3 Medical Industries Within 10 Years

Can tech giant Google disrupt these three medical industries, currently dominated by Roche, DexCom, and Allscripts?

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services